Focus on virosomes

Pevion Biotech successfully applies its proprietary virosome-based technology platform to the development of efficient and safe prophylactic/therapeutic vaccines. Pevion Biotech is located in Ittigen, Switzerland and has 26 employees.

 Pevion Biotech´s highly qualified scientists and development personnel are specialized in bringing novel vaccines from research into clinical development.

 Pevion Biotech´s virosomes are already market approved and can be manufactured in a large scale under GMP.

 Pevion Biotech´s technology can be adapted to meet the various requirements of a state-of-the-art carrier and adjuvant system.

 Pevion Biotech is a partner in vaccine formulation to pharmaceutical companies and research institutions.

For more information please download:
Corporate Profile Fact Sheet